Key indicators: single-crystal X-ray study; T = 120 K; mean (C-C) = 0.006 Å; disorder in main residue; R factor = 0.062; wR factor = 0.127; data-to-parameter ratio = 15.4.
Two independent molecules comprise the crystallographic asymmetric unit in the title antiretroviral agent Efavirenz, C 14 H 9 ClF 3 NO 2 , and these have noteworthy differences in conformation. The major difference relates to the orientation of the 2-cyclopropylethynyl residue relative to the sixmembered heterocycle: this approaches an orthogonal disposition in molecule a compared to a more flattened conformation in molecule b, the difference being reflected in the O ring -C-C-C ethyne torsion angles of 65 (4) and 159 (5) , respectively. The independent molecules are connected via the eightmembered {Á Á ÁHNC (O)} 2 amide synthon. Disorder is noted in the cyclopropane ring of molecule b in that two orientations of equal weight were discerned.
Related literature
For background to the use of Efavirenz, see: Adkins & Noble (1998) ; Gazzard (1999) 
Experimental
Crystal data C 14 H 9 ClF 3 NO 2 M r = 315.67 Orthorhombic, P2 1 2 1 2 1 a = 8.1403 (4) Å b = 13.5859 (11) Å c = 24.962 (2) Å V = 2760.6 (3) Å 3 Z = 8 Mo K radiation = 0.31 mm À1 T = 120 K 0.28 Â 0.08 Â 0.04 mm
Data collection
Bruker-Nonius 95mm CCD camera on -goniostat diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 2003) T min = 0.917, T max = 0.988 18370 measured reflections 6099 independent reflections 3675 reflections with I > 2(I) R int = 0.064 Refinement R[F 2 > 2(F 2 )] = 0.062 wR(F 2 ) = 0.127 S = 1.03 6099 reflections 395 parameters 5 restraints H atoms treated by a mixture of independent and constrained refinement Á max = 0.26 e Å À3 Á min = À0.25 e Å À3 Absolute structure: Flack (1983) , 2598 Friedel pairs Flack parameter: 0.14 (8) Table 1 Hydrogen-bond geometry (Å , ). Data collection: COLLECT (Hooft, 1998) ; cell refinement: DENZO (Otwinowski & Minor, 1997) and COLLECT; data reduction: DENZO and COLLECT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2009 ).
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Comment
The title anti-retroviral agent, Efavirenz, is a second-generation non-nucleoside inhibitor of HIV-1 reverse transcriptase (RT) that has been approved for use against HIV-1 infection. It is also called Sustiva or Stocrin and is manufactured by Bristol-Myers Squibb. Compared with first-generation drugs such as nevirapine, Efavirenz shows greater resilience to drug resistance mutations within HIV-1 RT. Effective treatment through inhibition of HIV reverse transcriptase has been shown for both nucleoside based inhibitors, such as azidothymidine, and non-nucleoside based inhibitors, such as Efavirenz. Efavirenz is also used in combination with other anti-retroviral agents as part of an expanded post-exposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk (Adkins & Noble, 1998; Gazzard, 1999; de Clercq et al., 2009; Markowitz et al., 2009; Young et al., 2009) .
Two independent molecules comprise the asymmetric unit in (I), labelled a and b, Fig. 1 . There are significant differences in conformation between the molecules and these relate primarily to the disposition of the 2-cyclopropylethynyl residue to the six-membered hetero-ring. As seen from Fig. 1 , each hetero ring adopts a flattened half-chain conformation with the C4a and C4b atoms being the pivotal atoms. In molecule a, the C4a atom is orientated towards the same side of the six-membered ring as the 2-cyclopropylethynyl residue which occupies a position orthogonal to the six-membered ring as seen in the O3a/C4a/C10a/C11a torsion angle of 65 (4) °. In molecule b, the C4b atom and 2-cyclopropylethynyl residue lie to opposite sides of the six-membered ring and the comparable torsion angle is 159 (5) °. The independent molecules associate via the eight-membered {···HNC(O)} 2 amide synthon, Table 1 and Fig. 1 .
Experimental
Crystals used in the crystallographic study were grown from aqueous methanol solution of (I).
Refinement
The C-bound H atoms were geometrically placed (C-H = 0.95-1.00 Å) and refined as riding with U iso (H) = 1.2U eq (C).
The amide-N H atoms were refined freely, see Table 1 for distances. Disorder was resolved for the cyclopropane ring of molecule b in that two positions, of equal weight (from refinement), were discerned for one of wing C atoms, C14b, so that each component of the disordered ring shared two atoms, C12b and C13b. Least-squares matrix: full H atoms treated by a mixture of independent and constrained refinement (3) C4BA-C5B-H5C 120.1 O2A-C2A-N1A 124.9 (4) C5B-C6B-C7B 120.9 (3) O2A-C2A-O3A 117.6 (3) C5B-C6B-Cl1B 119.1 (3) N1A-C2A-O3A 117.5 (3) C7B-C6B-Cl1B 120.0 (3) O3A-C4A-C10A 109.6 (3) C8B-C7B-C6B 119.5 (4) O3A-C4A-C4AA 110.4 (3) C8B-C7B-H7C 120.2 C10A-C4A-C4AA 110.0 (3) C6B-C7B-H7C 120.2 O3A-C4A-C9A 100.9 (3) C7B-C8B-C8BA 119.9 (3) C10A-C4A-C9A 111.1 (3) C7B-C8B-H8C 120.1 C4AA-C4A-C9A 114.4 (3) C8BA-C8B-H8C 120.1 C5A-C4AA-C8AA 120.1 (3) C8B-C8BA-C4BA 121.1 (3) C5A-C4AA-C4A 124.6 (3) C8B-C8BA-N1B 121.1 (3) C8AA-C4AA-C4A 115.1 (3) C4BA-C8BA-N1B 117.8 (3) C4AA-C5A-C6A 119.3 (3) F2B-C9B-F1B 108.3 (3) C4AA-C5A-H5A 120.3 F2B-C9B-F3B 107.5 (3) C6A-C5A-H5A 120.3 F1B-C9B-F3B 106.6 (4) C5A-C6A-C7A 121.7 (4) F2B-C9B-C4B 112.0 (4) C5A-C6A-Cl1A 118.2 (3) F1B-C9B-C4B 111.4 (3) C7A-C6A-Cl1A 120.1 (3) F3B-C9B-C4B 110.8 (3) C6A-C7A-C8A 118.7 (4) C11B-C10B-C4B 174.7 (4) C6A-C7A-H7A 120.6 C10B-C11B-C12B 178.3 (6) C8A-C7A-H7A 120.6 C13B-C12B-C11B 120.4 (5) C8AA-C8A-C7A 120.0 (4) C13B-C12B-C14B 63.7 (6) C8AA-C8A-H8A 120.0 C11B-C12B-C14B 113.4 (6) supplementary materials sup-9
Hydrogen-bond geometry (Å, °) D-H···A D-H H···A D···A D-H···A N1A-H1A···O2B 0.85 (4) 2.00 (4) 2.834 (4) 167 (4) N1B-H1C···O2A 0.89 (4) 1.94 (4) 2.820 (4) 168 (4) 
